Community News

Innovation in Health Care Technology Conference Focuses on Achieving an Improved Health Care System

Innovation and the introduction of new technologies into the marketplace can play a significant role in increasing access to health care while improving the quality of care and managing costs.  Carnegie Mellon University’s Innovation in Health Care Technology Conference brings together, entrepreneurs, policy makers, pioneers in new medical devise, IT and biopharma technology and health care industry experts for a full day of discourse on Friday, April 5, 2013 on the CMU campus.

The agenda will consist of 3 keynote presentations and 4 individual panels focused on the topics of: addressing healthcare policy, biopharma challenges and opportunities, entrepreneurship and health IT Attendees will be welcomed by Heinze college Dean Ramayya Krishnan and closing remarks will be presented by Robert M. Dammon, dean of the Tepper School of Business.   

What:                Innovation in Health Care Technology Conference

When:               Friday- April 5, 2013

                           9 a.m. – registration, 4:30 - concluding remarks

 Where:            Carnegie Mellon University

                           University Center- Rangos Hall


 Keynote Speakers

  • Raymond W. Urbanski, Mylan
  • Pat Basu, Virtual Radiologic
  • Larry Miller, Innovation Works

Health Care IT Panel

  • Rema Padman, Carnegie Mellon University’s Heinz College (Moderator)
  • Kenneth Zalevsky, Bayer
  • Andrew Watson, UPMC
  • Michael S. Weiner, Department of Defense
  • Juergen Fritsch, M*Modal

Entrepreneurship Panel

  • James Jordan, Sr., Carnegie Mellon University’s Heinz College (Moderator)
  • Daniel Bishop, Qualaris Healthcare Solutions
  • Rick Cancelliere, Health 2.0 Pittsburgh
  • Christopher Hayes, Net Health Systems
  • Patrick Colletti, Net Health Systems
  • Christopher R. Evans, TrueFit Innovation

Health Policy Panel

  • Francesca Pillemer, RAND Corporation (Moderator)
  • Karen Feinstein, Jewish Healthcare Foundation
  • Susan Straus, Rand Corporation
  • Ateev Mehrotra, UPMC/RAND
  • Lee Kim, Tucker Arensberg

BioPharma Panel

  • Arthur Boni, Tepper School of Business (Moderator)
  • Dave Eiben, Boehringer Ingelheim
  • Yali Friedman, Scientific American Global Biowatch, J. Commercial Biotechnology
  • Matt Hawryluk, Foundation Medicine
  • Chad Holland, Mylan
Additional information is available on the event website: